Showing results (11-20 of 38) with videos related to
Sort By:
Pageof 4
Expert Opinion on Drug Delivery|February 21, 2012
Recent trends in cancer drug resistance reversal strategies using nanoparticlesSrinath Palakurthi, Venkata Kashyap Yellepeddi, Kiran Kumar VangaraDrug Delivery|August 23, 2008
Transport of surface engineered polyamidoamine (PAMAM) dendrimers across IPEC-J2 cell monolayersDipak S Pisal, Venkata K Yellepeddi, Ajay Kumar, et al.Anticancer Research|September 21, 2012
Comparative evaluation of small-molecule chemosensitizers in reversal of cisplatin resistance in ovarian cancer cellsVenkata K Yellepeddi, Kiran K Vangara, Ajay Kumar, et al.Anticancer Research|November 5, 2014
Transcriptional targeting of human liver carboxylesterase (hCE1m6) and simultaneous expression of anti-BCRP shRNA enhances sensitivity of breast cancer cells to CPT-11Mukti N Mishra, Mukthi N Mishra, Kiran K Vangara, et al.Nanotoxicology|March 31, 2016
Safety and toxicity of nanomaterials for ocular drug delivery applicationsNeelesh K Mehra, Defu Cai, Lih Kuo, et al.International Journal of Biological Macromolecules|October 3, 2020
Natural proteins and polysaccharides in the development of micro/nano delivery systems for the treatment of inflammatory bowel diseaseBrijesh M Shah, Sushesh Srivatsa Palakurthi, Tripti Khare, et al.International Journal of Molecular Sciences|June 4, 2020
Natural Product-Based Nanomedicine in Treatment of Inflammatory Bowel DiseaseTripti Khare, Sushesh Srivatsa Palakurthi, Brijesh M Shah, et al.Journal of Drug Targeting|April 5, 2011
Mechanism of gene transfection by polyamidoamine (PAMAM) dendrimers modified with ornithine residuesAjay Kumar, Venkata K Yellepeddi, Kiran K Vangara, et al.International Journal of Pharmaceutics|April 6, 2010
Enhanced gene transfection efficiency by polyamidoamine (PAMAM) dendrimers modified with ornithine residuesAjay Kumar, Venkata K Yellepeddi, Gareth E Davies, et al.AAPS Pharmscitech|January 31, 2014
SN-38-cyclodextrin complexation and its influence on the solubility, stability, and in vitro anticancer activity against ovarian cancerKiran Kumar Vangara, Hamed Ismail Ali, Dai Lu, et al.Pageof 4